These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30114440)

  • 21. Experimental Models to Study Immune Dysfunction in the Pathogenesis of Parkinson's Disease.
    Saponjic J; Mejías R; Nikolovski N; Dragic M; Canak A; Papoutsopoulou S; Gürsoy-Özdemir Y; Fladmark KE; Ntavaroukas P; Bayar Muluk N; Zeljkovic Jovanovic M; Fontán-Lozano Á; Comi C; Marino F
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease.
    Gelders G; Baekelandt V; Van der Perren A
    J Immunol Res; 2018; 2018():4784268. PubMed ID: 29850629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fat and Protein Combat Triggers Immunological Weapons of Innate and Adaptive Immune Systems to Launch Neuroinflammation in Parkinson's Disease.
    Hatton SL; Pandey MK
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson's Disease.
    Kustrimovic N; Marino F; Cosentino M
    Curr Med Chem; 2019; 26(20):3719-3753. PubMed ID: 30306855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Periphery and brain, innate and adaptive immunity in Parkinson's disease.
    Harms AS; Ferreira SA; Romero-Ramos M
    Acta Neuropathol; 2021 Apr; 141(4):527-545. PubMed ID: 33555429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammation and Parkinson's disease.
    Wersinger C; Sidhu A
    Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):221-42. PubMed ID: 14561187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an α-synuclein-based rat model for Parkinson's disease.
    Van der Perren A; Macchi F; Toelen J; Carlon MS; Maris M; de Loor H; Kuypers DR; Gijsbers R; Van den Haute C; Debyser Z; Baekelandt V
    Neurobiol Aging; 2015 Mar; 36(3):1559-68. PubMed ID: 25660193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of innate and adaptive immunity in Parkinson's disease.
    Kannarkat GT; Boss JM; Tansey MG
    J Parkinsons Dis; 2013; 3(4):493-514. PubMed ID: 24275605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based Therapies.
    Rocha NP; de Miranda AS; Teixeira AL
    Biomed Res Int; 2015; 2015():628192. PubMed ID: 26295044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of CD4+ T Cells in Parkinson's Disease.
    Ghanta MK; Nuthalapati P; Merchant N; Chenchula S; Hussain F; Ak AK; Bhaskar LVKS
    Crit Rev Immunol; 2022; 42(6):17-25. PubMed ID: 37082948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Innate and adaptive immunity for the pathobiology of Parkinson's disease.
    Stone DK; Reynolds AD; Mosley RL; Gendelman HE
    Antioxid Redox Signal; 2009 Sep; 11(9):2151-66. PubMed ID: 19243239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease models.
    Tai W; Ye X; Bao X; Zhao B; Wang X; Zhang D
    Neuropharmacology; 2013 Dec; 75():201-12. PubMed ID: 23916477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roles for the adaptive immune system in Parkinson's and Alzheimer's diseases.
    Lindestam Arlehamn CS; Garretti F; Sulzer D; Sette A
    Curr Opin Immunol; 2019 Aug; 59():115-120. PubMed ID: 31430650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel anti-inflammatory therapy for Parkinson's disease.
    Gao HM; Liu B; Zhang W; Hong JS
    Trends Pharmacol Sci; 2003 Aug; 24(8):395-401. PubMed ID: 12915048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroinflammation - A major cause for striatal dopaminergic degeneration in Parkinson's disease.
    Kaur K; Gill JS; Bansal PK; Deshmukh R
    J Neurol Sci; 2017 Oct; 381():308-314. PubMed ID: 28991704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammation in Parkinson's disease.
    Tufekci KU; Meuwissen R; Genc S; Genc K
    Adv Protein Chem Struct Biol; 2012; 88():69-132. PubMed ID: 22814707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parkinson's disease and enhanced inflammatory response.
    Stojkovska I; Wagner BM; Morrison BE
    Exp Biol Med (Maywood); 2015 Nov; 240(11):1387-95. PubMed ID: 25769314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. M1 and M2 immune activation in Parkinson's Disease: Foe and ally?
    Moehle MS; West AB
    Neuroscience; 2015 Aug; 302():59-73. PubMed ID: 25463515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A dysfunction of CD4+ T lymphocytes in peripheral immune system of Parkinson's disease model mice.
    Huang Y; Liu Z; Wang XQ; Qiu YH; Peng YP
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Nov; 30(6):567-76. PubMed ID: 26016368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells.
    Garretti F; Agalliu D; Lindestam Arlehamn CS; Sette A; Sulzer D
    Front Immunol; 2019; 10():303. PubMed ID: 30858851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.